Cardiff Oncology, Inc. (CRDF) › Weighted Average Diluted SharesCardiff Oncology, Inc. (CRDF) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2012-12-31: 13.07M2013-12-31: 16.98M2014-12-31: 19.07M2015-12-31: 26.45M2016-12-31: 30.28M2017-12-31: 481.7K2018-12-31: 2.33M2020-12-31: 20.88M2021-12-31: 39.03M2022-12-31: 43.60M2023-12-31: 44.68M2024-12-31: 47.65M2025-12-31: 66.84M66.84M2012-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3166.84M+40.3%2026-02-24From 2025-01-012024-12-3147.65M+6.7%2026-02-24From 2024-01-012023-12-3144.68M+2.5%2025-02-27From 2023-01-012022-12-3143.60M+11.7%2024-02-29From 2022-01-012021-12-3139.03M+87.0%2023-03-02From 2021-01-012020-12-3120.88M—2022-02-24From 2020-01-012018-12-312.33M+383.8%2019-03-06From 2018-01-012017-12-31481.7K-98.4%2019-03-06From 2017-01-012016-12-3130.28M+14.5%2018-02-26From 2016-01-012015-12-3126.45M+38.7%2017-03-15From 2015-01-012014-12-3119.07M+12.3%2017-03-15From 2014-01-012013-12-3116.98M+29.9%2016-03-10From 2013-01-012012-12-3113.07M—2015-03-12From 2012-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)